Furthermore, it explores potential therapeutic targets for VNS in modulating NLRP3 inflammasome, offering valuable insights for subsequent interventions in cardiovascular diseases through ANS-mediated NLRP3 inflammasome pathways. The gene discussed is NLRP3; the disease is cardiovascular disorder.